Simon James Yvon Saxby
Amministratore Delegato presso Cobra Biologics Holdings Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Peter Coleman | M | 57 |
Cobra Biologics Holdings Ltd.
 Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 22 anni |
| William John Edward Burt | M | 56 |
Leaf Systems International Ltd.
 Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Sheena Pumford | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 27 anni |
| David John Simpson | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Georgina Anne Pope | M | 49 |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Colin Malcolm Miles | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
| Simon Eric Aspland | M | - |
Leaf Systems International Ltd.
Leaf Systems International Ltd. Pharmaceuticals: OtherHealth Technology Leaf Systems International Ltd. is a contract research and British product development company that specializes in cutting-edge plant-based expression and production of proteins. The company is based in Norwich, UK. The company has a strong focus on research and development, utilizing their versatile technology and knowledge of plant biotechnology. The CEO of the company is Simon James Yvon Saxby. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David A. Thatcher | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| David Aufrere Oxlade | M | 74 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 4 anni |
| Michael Gatenby | M | 79 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Danny R. Chapchal | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Nigel Slater | M | 70 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 12 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Simon James Yvon Saxby
- Contatti personali
